Octreotide Acetate

19 interactions 1 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Acarbose Miglitol Insulin Glulisine (Rdna Origin) Injection Dapagliflozin Dulaglutide Injection Nateglinide

19 Major

All (19) Major (19)

Major

Octreotide Acetate Acarbose Prandase® Explained An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Alogliptin Nesina An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Canagliflozin Invokana An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Dapagliflozin Farxiga An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Dulaglutide Injection Trulicity An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Ertugliflozin Steglatro An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Exenatide Injection Bydureon An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Glimepiride Amaryl An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Glipizide Glucotrol An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Insulin Detemir (Rdna Origin) Injection Levemir An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Insulin Glulisine (Rdna Origin) Injection Apidra An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Linagliptin Tradjenta An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Liraglutide Injection Saxenda An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Lixisenatide Injection Adlyxin® An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Metformin Fortamet® An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Miglitol Glyset® An increased risk of hypoglycemia and impaired glucose regulation Details Octreotide Acetate Nateglinide Starlix® An increased risk of hypoglycemia and impaired glucose regulation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.